The study will be presented on Monday, May 19, highlighting key advancements in Xentria's investigational monoclonal antibody therapy for pulmonary sarcoidosis. Further demonstrating its ...

From the departments of Medicine, Veterans Administration Hospital, George Washington University and Georgetown University. Washington, D. C. (address reprint requests to Dr. Becker at 50 Irving ...

Xentria, a clinical-stage biopharmaceutical company advancing therapies for rare and serious diseases, today announced the successful completion of enrollment in the therapeutic dose-ranging phase of ...